Ponezumab

DB15135InvestigationalProtein Based Therapies

Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).

Mechanism: Pharmacologically active on Amyloid-beta precursor protein
Curator reviewed
Also known as: PF-04360365

Resolves to

Compound

UNII1TG15H1XE9CAS1178862-65-1

Targets

P05067APP

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

382Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ponezumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account